explore -WSS

explore

author：knowledge 2025-10-01 02:15:27 - browse：78

Mini people figurines stand in line beside a stethoscope. -- health business coverage from STAT — Adobe

It’s the middle of October — the time of year that’s filled with pumpkin spice lattes, jumbo-sized bags of Halloween candy, and endless advertisements to sign up for Medicare.

Medicare’s annual enrollment period kicked off Sunday and runs through Dec. 7, allowing eligible older adults and people with disabilities to sign up for traditional Medicare coverage or Medicare Advantage, the alternative option that is run by health insurance companies.

A lot is changing during this year’s enrollment window. The federal government is cracking down on deceptive TV ads and other messaging that exaggerate the benefits of, or hide the potential flaws of, Medicare Advantage plans. The Senate Finance Committee is holding a hearing this week on that same topic. Prescription drug plan premiums also are fluctuating a lot in many areas in response to provisions embedded in the Inflation Reduction Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： At ASCO, AstraZeneca reports strong data for breast cancer drug

focus

hotspot

WSS

NIH documents show early flaws of $1.6 billion long Covid program

Letters to First Opinion on caregivers, digital health, and more

ASCO: AstraZeneca says CAR

Lilly’s weekly insulin works as well as daily products, new studies show

Ripples from Flovent's discontinuation is killing children with asthma

As H5N1 spreads in cows, experts warn against drinking raw milk

entertainment

explore

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Shifting the focus from loneliness to social health

Activists slam private health insurers over coverage restrictions

Galapagos to make CAR

Alkermes shareholders re

Obesity drug from Roche shows promise in early study

Malaria cases in Florida and Texas: Here’s what you need to know

With trial win, GSK could get blood cancer drug back on market

Medicare details structure of new drug price negotiation program

Ionis drug prevents swelling attacks due to hereditary angioedema

hotspot

Woman returns to dialysis after doctors remove transplanted pig kidney

Hottest summer in 2,000 years puts focus on extreme heat, health

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Change Healthcare can notify patients about the breach, HHS says

focus

hotspot

focus

focus